Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy

スポンサーリンク

概要

• 論文の詳細を見る
• 2010-03-01

著者

• Uemura Hirotsugu

  Departments Of Urology Kinki University School Of Medicine

• Uemura Hirotsugu

  Department Of Urology Kinki University School Of Medicine

• Tomita Yoshihiko

  Department of Urology, Graduate School of Medical and Dental Sciences, Niigata Universily

• Tomita Yoshihiko

  Department Of Urology Course Of Metabolic And Regenerative Medicine Yamagata University Faculty Of M

• Tomita Yoshihiko

  Department Of Urology Yamagata University

• Yao Masahiro

  Yokohama City University

• OHLMANN Carsten

  Department of Urology, Saarland University Hospital

• BUKOWSKI Ronald

  Cleveland Clinic Taussig Cancer Center

• NAITO Sei

  Department of Urology, Yamagata University

• Naito Sei

  Department Of Urology Yamagata University

• Uemura Hirotsugu

  Department Of Urology Kinki University

• Ohlmann Carsten

  Department Of Urology Saarland University Hospital

関連論文

• S9 Renal Cell Carcinoma : Developing Therapeutic Approaches(Keynote Lecture,Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)
• Medial prefrontal cortex lesions inhibit reflex micturition in anethetized rats
• Thiol crosslinking agent Diamide was effective to induce apoptosis in multidrug resistant TCC cells
• Adoptive Immunotherapy of Patients with Metastatic Renal Cell Cancer Using Lymphokine-Activated Killer Cells, Interleukin-2 and Cyclophosphamide: Long-Term Results
• Serum ICAM-1 in Renal Cell Cancer Patients : Possible Significance for Presence of Metastatic Disease
• Long-term results of transurethral microwave thermotherapy
• A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer
• Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
• S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)
• S9: Introduction(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)
• CORRELATION OF p53 PROTEIN EXPRESSION IN HUMAN UROTHELIAL TRANSITIONAL CELL CANCERS WITH MALIGNANT POTENTIAL AND PATIENT SURVIVAL
• The prevalence of renal cell carcinoma : A nation-wide survey in Japan in 1997
• WS1-3-5 A Prostate Cancer Model by the Prostate Specific Deletion of PTEN(Prostate Cancer)
• Aberrations of the p14^ and p16^ Genes in Renal Cell Carcinomas
• Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation
• Analysis of bone mineral density in urolithiasis patients
• Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma
• Early renal cell cancer
• Absence of RET Proto-Oncogene Mutations in a Father and Son with Pheochromocytoma and Pancreatic Islet Cell Tumor
• Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy
• Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate
• Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress
• Editorial Comment to Treatment outcomes of sorafenib for first line or cytokine-refractory advanced renal cell carcinoma in Japanese patients
• Reduced-intensity stem cell transplantation in two cases of metastatic renal cell carcinoma
• Exploring immune therapy for renal cancer

もっと見る 閉じる

スポンサーリンク